Optimizing RNA extraction methods for high-throughput transcriptome sequencing of formalin-fixed paraffin-embedded cardiac tissue specimens

PLoS One. 2024 Dec 26;19(12):e0315098. doi: 10.1371/journal.pone.0315098. eCollection 2024.

Abstract

Archived FFPE cardiac tissue specimens are valuable for molecular studies aimed at identifying biomarkers linked to mortality in cardiovascular disease. Establishing a reliable and reproducible RNA extraction method is critical for generating high-quality transcriptome sequences for molecular assays. Here, the efficiency of four RNA extraction methods: Qiagen AllPrep DNA/RNA method (Method QP); Qiagen AllPrep DNA/RNA method with protocol modification on the ethanol wash step after deparaffinization (Method QE); CELLDATA RNA extraction (Method BP) and CELLDATA RNA extraction with protocol modifications on the lysis step (Method BL) was compared on 23 matching FFPE cardiac tissue specimens (n = 92).In comparing RNA quality metrics across FFPE RNA extract, nucleic acids extracted deploying Method QE and QP produced the highest RNA yield. However, Method QE outperformed Method QP as more extract from Method QE had DV 200 values above 30%. Both method BL and BP produced similar range of RNA purity and yield but more extract from Method BL had DV 200 values above 30% compared to Method BP. When accessing distribution value, Method BL outperformed Methods BP, QE, and QP as more extracts from Method BL had DV 200 values above 30% compared to other methods (PDV200<0.001; Kruskal-Wallis). Method QE outperformed other methods in terms of RNA yield. RNA extracts from Method QE, characterized by high RNA yield, achieved sequencing results comparable to those from Method BL, characterized by high DV200 values. Our findings reveal that optimizing protocols can yield higher-quality RNA, facilitating the exploration of more disease conditions with high-resolution transcriptome profiling.

MeSH terms

  • Formaldehyde* / chemistry
  • Gene Expression Profiling / methods
  • High-Throughput Nucleotide Sequencing* / methods
  • Humans
  • Myocardium* / metabolism
  • Paraffin Embedding* / methods
  • RNA* / analysis
  • RNA* / genetics
  • RNA* / isolation & purification
  • Sequence Analysis, RNA / methods
  • Tissue Fixation* / methods
  • Transcriptome

Substances

  • Formaldehyde
  • RNA

Grants and funding

This project was funded by Mayo Clinic Program for Hypoplastic Left Heart Syndrome. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.